GENDER AND BMI-SPECIFIC ANTICHOLINERGIC PERSISTENCE AND ADHERENCE IN PATIENTS WITH OVERACTIVE BLADDER

被引：0
|
作者：
Lua, Lannah [1 ]
Parm, Prathamesh [1 ]
Albanese, Jessica [1 ]
Dandolu, Vani [1 ]
机构：
[1] Univ Nevada, Sch Med, Las Vegas, NV 89154 USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
NM33
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] IS SELF REPORTED ADHERENCE ASSOCIATED WITH CLINICAL OUTCOMES IN WOMEN UNDERGOING TREATMENT WITH ANTICHOLINERGIC MEDICATIONS FOR OVERACTIVE BLADDER?
    Andy, U. U.
    Arya, L.
    Harvie, H. S.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S205 - S206
  • [32] Is self-reported adherence associated with clinical outcomes in women treated with anticholinergic medication for overactive bladder?
    Andy, Uduak U.
    Arya, Lily A.
    Smith, Ariana L.
    Propert, Kathleen J.
    Bogner, Hillary R.
    Colavita, Kristen
    Harvie, Heidi S.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (06) : 738 - 742
  • [33] PERSISTENCE WITH ANTIMUSCARINICS IN A EUROPEAN STUDY OF PATIENTS WITH OVERACTIVE BLADDER SYNDROME
    Blok, B.
    Van Kerrebroeck, P.
    Buijs, S.
    De Vries, C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S192 - S193
  • [34] The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder
    Suehs, Brandon T.
    Caplan, Eleanor O.
    Hayden, Jennifer
    Ng, Daniel B.
    Gaddy, Rainelle R.
    DRUGS & AGING, 2019, 36 (10) : 957 - 967
  • [35] Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder?
    Linda Cardozo
    Sender Herschorn
    Robert Snijder
    Emad Siddiqui
    Christopher R. Chapple
    International Urogynecology Journal, 2017, 28 : 477 - 488
  • [36] DO BMI, GENDER OR AGE AFFECT THE EFFICACY OR TOLERABILITY OF SOLIFENACIN IN THE MANAGEMENT OF OVERACTIVE BLADDER?
    Cardozo, L.
    Herschorn, S.
    Snijder, R. J.
    Siddiqui, E.
    Chapple, C. R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2016, 27 : S28 - S29
  • [37] Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder?
    Cardozo, Linda
    Herschorn, Sender
    Snijder, Robert
    Siddiqui, Emad
    Chapple, Christopher R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 (03) : 477 - 488
  • [38] IMPACT OF GENDER ON TREATMENT JOURNEY FOR PATIENTS WITH OVERACTIVE BLADDER
    Chung, Amanda S. J.
    Miles-Thomas, Jennifer
    DeLong, Jessica
    Virasoro, Ramon
    Tonkin, Jeremy
    McCammon, Kurt A.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S69 - S69
  • [39] Overactive Bladder Medication Adherence When Medication is Free to Patients
    Sears, Christine L. G.
    Lewis, Christa
    Noel, Kathleen
    Albright, Todd S.
    Fischer, John R.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 1077 - 1081
  • [40] Comparative Adherence of Overactive Bladder Agents Among Older Patients
    Singh, Samantha
    Khuu, Wayne
    Tadrous, Mina
    Martins, Diana
    Mamdani, Muhammad
    Elterman, Dean
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 41 - 42
12345